iTeos Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
12 Oct 23 | BuyUS$41,850 | Matthew Gall | Individual | 5,000 | US$8.37 | |
23 Aug 23 | SellUS$5,692,673 | Tavistock Life Sciences | Company | 350,000 | US$16.87 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 9,870 | 0.0265% |
Individual Insiders | 134,590 | 0.361% |
General Public | 1,664,336 | 4.47% |
Hedge Funds | 1,999,249 | 5.36% |
VC/PE Firms | 9,344,746 | 25.1% |
Institutions | 24,112,988 | 64.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
4,114,820 | US$61.1m | -3.45% | no data | |||
3,659,046 | US$54.3m | -17.2% | 0.75% | |||
2,946,915 | US$43.7m | 63.4% | 2.35% | |||
2,738,785 | US$40.6m | 0% | 16.34% | |||
1,999,249 | US$29.7m | 79.3% | 0.91% | |||
1,745,943 | US$25.9m | 0% | 4.77% | |||
1,500,602 | US$22.3m | 0.65% | no data | |||
1,481,925 | US$22.0m | 48% | no data | |||
1,168,664 | US$17.3m | 3.44% | 0.02% | |||
1,162,374 | US$17.2m | 0% | 1.09% | |||
882,981 | US$13.1m | -8.73% | 0.01% | |||
791,170 | US$11.7m | 2.33% | no data | |||
723,000 | US$10.7m | 0% | 0.21% | |||
717,300 | US$10.6m | 2.63% | 0.02% | |||
715,000 | US$10.6m | 0% | 1.09% | |||
583,520 | US$8.7m | 2.58% | no data | |||
577,545 | US$8.6m | 4.71% | no data | |||
504,545 | US$7.5m | -5.63% | 0.03% | |||
421,677 | US$6.3m | -9.09% | no data | |||
387,095 | US$5.7m | -53.3% | 2.36% | |||
370,600 | US$5.5m | 92.1% | no data | |||
346,325 | US$5.1m | 10.8% | no data | |||
300,000 | US$4.5m | 0% | 0.66% | |||
295,984 | US$4.4m | -14.2% | no data | |||
294,580 | US$4.4m | 5.87% | no data |